Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction.


Journal

Trends in biotechnology
ISSN: 1879-3096
Titre abrégé: Trends Biotechnol
Pays: England
ID NLM: 8310903

Informations de publication

Date de publication:
04 2020
Historique:
received: 18 12 2019
accepted: 18 12 2019
pubmed: 6 2 2020
medline: 16 7 2021
entrez: 5 2 2020
Statut: ppublish

Résumé

As public interest advocates, policy experts, bioethicists, and scientists, we call for a course correction in public discussions about heritable human genome editing. Clarifying misrepresentations, centering societal consequences and concerns, and fostering public empowerment will support robust, global public engagement and meaningful deliberation about altering the genes of future generations.

Identifiants

pubmed: 32014274
pii: S0167-7799(19)30317-8
doi: 10.1016/j.tibtech.2019.12.022
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

351-354

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Roberto Andorno (R)

School of Law of the University of Zurich, Zurich, Switzerland.

Françoise Baylis (F)

Dalhousie University, Halifax, NS, Canada.

Marcy Darnovsky (M)

Center for Genetics and Society, Berkeley, CA, USA.

Donna Dickenson (D)

Medical Ethics and Humanities, University of London, London, UK.

Hille Haker (H)

Loyola University Chicago, Chicago, IL, USA.

Katie Hasson (K)

Center for Genetics and Society, Berkeley, CA, USA. Electronic address: khasson@geneticsandsociety.org.

Leah Lowthorp (L)

University of Oregon, Eugene, OR, USA.

George J Annas (GJ)

Center for Health Law, Ethics and Human Rights, Boston University School of Public Health, Boston, MA, USA.

Catherine Bourgain (C)

Center for Research in Medicine, Science, Health, Mental Health, and Society, National Institute of Health and Medical Research (INSERM), Paris, France.

Katherine Drabiak (K)

College of Public Health and College of Medicine, University of South Florida, Tampa, FL, USA.

Sigrid Graumann (S)

Protestant University of Applied Sciences, Bochum, Germany.

Katrin Grüber (K)

Institut Mensch, Ethik und Wissenschaft, Berlin, Germany.

Matthias Kaiser (M)

Centre for the Study of the Sciences and Humanities (SVT), University of Bergen, Bergen, Norway.

David King (D)

Human Genetics Alert, London, UK.

Regine Kollek (R)

Hamburg University, Hamburg, Germany.

Calum MacKellar (C)

Scottish Council on Human Bioethics, Edinburgh, UK.

Jing-Bao Nie (JB)

Bioethics Centre, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand; Peking University Health Science Center, Beijing, China.

Osagie K Obasogie (OK)

Center for Genetics and Society, Berkeley, CA, USA; University of California, Berkeley, Joint Medical Program, School of Public Health, Berkeley, CA, USA.

Mirriam Tyebally Fang (M)

Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland.

Gabriele Werner-Felmayer (G)

Institute of Biological Chemistry and Bioethics Network Ethucation, Medical University of Innsbruck, Innsbruck, Austria.

Jana Zuscinova (J)

EPP Working Group on Bioethics and Human Dignity, European Parliament, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH